The report on the Global Ophthalmology Drugs And Devices Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Drivers
- Growing geriatric population
- Rising occurrences of eye allergic and diseases
Restraints
- Dearth of skill professionals
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:
- Base Year: 2019
- Estimated Year: 2020
- Forecast Till: 2026
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments based on devices and drugs. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
The report also covers the complete competitive landscape of the global ophthalmology drugs and devices market with company profiles of key players such as:
- Abbott Laboratories
- Allergan, Inc.
- Bausch & Lomb
- Carl Zeiss
- Johnson & Johnson
- Merck & Co.
- Nidek Inc.
- Novartis AG
- Pfizer Inc.
- Roche Holding AG
- Sanofi SA
- Topcon Corporation
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
SEGMENTATIONS IN THE REPORT:
By Devices:
- Lasers
- Glaucoma Surgery Devices
- Cataract Surgery Devices
- Refractive Surgery Devices
- Lenses
By Drugs:
- Anti-Glaucoma Drugs
- Dry Eye Drugs
- Retinal Disorders Drugs
- Anti-Inflammatory Drugs
By Geography:
- North America (NA) – US, Canada & Rest of North America
- Europe (EU) – UK, Germany, France & Rest of Europe
- Asia Pacific (APAC) – China, Japan, India & Rest of APAC
- Latin America (LA) – Brazil & Rest of Latin America
- Middle East & Africa (MEA) – Middle East and Africa
The Global Ophthalmology Drugs And Devices Market has been exhibited in detail in the following chapters -
Chapter 1 Ophthalmology Drugs And Devices Market Preface
Chapter 2 Executive Summary
Chapter 3 Ophthalmology Drugs And Devices Industry Analysis
Chapter 4 Ophthalmology Drugs And Devices Market Value Chain Analysis
Chapter 5 Ophthalmology Drugs And Devices Market Analysis By Devices
Chapter 6 Ophthalmology Drugs And Devices Market Analysis By Drugs
Chapter 7 Ophthalmology Drugs And Devices Market Analysis By Geography
Chapter 8 Competitive Landscape Of Ophthalmology Drugs And Devices Companies
Chapter 9 Company Profiles Of Ophthalmology Drugs And Devices Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.